Silo Pharma, Inc.
Develops novel psychedelic & traditional therapies for pain and central nervous system disorders.
SILO | US
Overview
Corporate Details
- ISIN(s):
- US82711P2011 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 677 N. WASHINGTON BLVD, 34236 SARASOTA
- Website:
- https://silopharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Silo Pharma, Inc. is a developmental-stage biopharmaceutical company focused on creating novel formulations of traditional and psychedelic therapeutics. The company targets underserved conditions, including stress-induced psychiatric disorders, chronic pain, and central nervous system (CNS) diseases. Its portfolio includes programs such as SPC-15 for PTSD and SP-26 for fibromyalgia, as well as preclinical assets for Alzheimer’s disease and multiple sclerosis. Silo Pharma utilizes the streamlined 505(b)(2) regulatory pathway to potentially lower costs and accelerate FDA approval. The company develops its intellectual property through exclusive collaborations with leading universities and research partners.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Silo Pharma, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Silo Pharma, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Silo Pharma, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
